NIH Exploratory/Developmental Cooperative Agreement Phase II (UH3)
Funds Exploratory/Developmental Cooperative Agreement Phase II awards, NIH's UH3 mechanism.
The Exploratory/Developmental Cooperative Agreement Phase II (UH3) is the UH3 award is to provide a second phase for the support for innovative exploratory and development research activities initiated under the UH2 mechanism. Although only UH2 awardees are generally eligible to apply for UH3 support, specific program initiatives may establish eligibility criteria under which applications could be…
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.
Funds the continuation of a dental clinical trial the institute already supports, or a competing revision that changes what it does.
Funds the clinical validation of a cancer biomarker assay whose analytical performance has already been proven.
Funds the small clinical trial that settles a brain device's final design — early feasibility studies, from short procedures to chronic implants.